Intelligence Platform

Patents

Browse 405 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9309535

Combination anti-HIV vectors, targeting vectors, and methods of use

The Regents of the University of California · Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9308211

Drug combinations and uses in treating a coughing condition

Infirst Healthcare Limited · Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9301920

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9302002

Etanercept formulations stabilized with combinations of sugars and polyols

Coherus BioSciences, Inc. · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9289451

Methods and compositions for targeted cleavage and recombination

Sangamo Biosciences, Inc. · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273143

Methods and compositions comprising a combination of an anti-ErbB3 antibody and an anti-EG

REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9243068

Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases

VACCINEX, INC. · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198893

Combination antitumor therapy

Galera Labs, LLC · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198907

Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic age

PTC THERAPEUTICS, INC. · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9138453

Nutrient combinations for affecting an aging process

BioMarker Pharmaceuticals, Inc. · Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9114145

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9114146

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9107887

Combination of local and systemic immunomodulative therapies for enhanced treatment of can

Provectus Pharmaceuticals, Inc. · Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9089531

GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA co

The Regents of the University of California · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9060971

Combination pharmaceutical agents as inhibitors of HCV replication

Enanta Pharmaceuticals, Inc. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9050343

Combination of pimavanserin and risperidone for the treatment of psychosis

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9012434

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9006222

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993548

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993549

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8986708

Combinations of gene deletions for live attenuated Shigella vaccine strains

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987238

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987237

Natural combination hormone replacement formulations and therapies

Compass Therapeutics LLC · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8951972

FGFR1 extracellular domain combination therapies for lung cancer

Five Prime Therapeutics, Inc. · Granted Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted